← SynDRA
MOLNUPIRAVIR
SynDRA canonical compound SYN0040150 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Mechanism of action | antiviral |
|---|
Mechanisms of action (all sources)
Drug classes
- Anti-Infective Agents
- Antiviral Agents
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- EIDD-2801
- N4-Hydroxycytidine
- Beta-D-N4-hydroxycytidine
- NHC
- MK-4482
- EIDD-1931 ISOPROPYL ESTER
- N4-Hydroxycytidine, 5'-isopropyl ester
- Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-
- MK 4482
- YA84KI1VEW
- Uridine, 4-oxime, 5'-(2-methylpropanoate)
- EIDD 2801
- beta-D-N4 Hydroxycytidine-5'-isopropyl ester
- Lagevrio
- EIDD2801
- CHEBI:180653
- MK4482
- RefChem:53379
- DTXCID401767659
- SARS-CoV-2 antiviral agents: molnupiravir
- Molnupiravir [INN]
- Molnupiravir [USAN]
- Molnupiravir [WHO-DD]
- MFCD32663515
- N-hydroxy-5'-O-(2-methylpropanoyl)cytidine
- Molnupiravir Impurity 7
- molnupiravirum
- Lagevrio (TN)
- XMO
- UNII-YA84KI1VEW
- pro-EIDD-1931
- Molnupiravir (JAN/USAN)
- MOLNUPIRAVIR [JAN]
- EIDD-2801(Molnupiravir)
- EIDD-2801(Molnupiravir)?
- Molnupiravir (EIDD-2801)
- orb1299050
- orb1689082
Reported adverse events
Look up MOLNUPIRAVIR in the interactive SynDRA portal →